Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA studyLiesbet De Bus, Mónica Crespo, Marc Léone et al.|Intensive Care Medicine|2020Cited by 117
Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic modelsSofie Dhaese, Jan J. De Waele, Andras Farkas et al.|Journal of Antimicrobial Chemotherapy|2018Cited by 53
Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational studySofie Dhaese, Jan J. De Waele, Alexander D.J. Thooft et al.|Journal of Critical Care|2019Cited by 51
Population pharmacokinetics of continuous infusion of piperacillin in critically ill patientsSofie Dhaese, Jan J. De Waele, Jason A. Roberts et al.|International Journal of Antimicrobial Agents|2017Cited by 44
Therapeutic drug monitoring of β-lactam antibiotics in the ICUSofie Dhaese, Jan J. De Waele, Sarah Van Vooren et al.|Expert Review of Anti-infective Therapy|2020Cited by 43